Companies: 10,795·Total market cap: $144.5T
ACS Global, Inc.

ACS Global, Inc.

AMCYOTCHealthcare
$3.00
$-2.00(-40.00%)
Market Cap$171271200
P/E Ratio
52W High$3.0
52W Low$3.0
Overview

ACS Global, Inc. (AMCY) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AMCY · as of Jun 8, 2026

Key Statistics

EPS (TTM)amcy eps ttm · amcy earnings per shareEarnings history
PE Ratio (TTM)amcy pe ratio ttm · amcy price to earningsPE Ratio deep dive
Revenue (TTM)amcy revenue ttm · amcy annual revenueFull revenue history
Dividend YieldNo Dividenddoes amcy pay dividends · amcy dividend yieldDividend history
Shares Outstandingamcy shares outstanding · amcy floatShares outstanding history
Next EarningsTBAamcy earnings date · amcy next earningsEarnings history

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-40.00%
5Y-40.00%

About ACS Global, Inc.

CEOAnthony Francis Dudzinski Jr.
IPO DateJan 8, 2021
Employees
CountryUS

ACS Global, Inc. specializes in the acquisition, meticulous processing, and secure, long-term cryogenic storage of stem cells. The company enables individuals to privately bank their own stem cells fo…

what is acs global, inc. · amcy stock overview · acs global, inc. company profile · who is acs global, inc. ceo · amcy OTC · acs global, inc. headquarters · acs global, inc. business segments

About Stock Overview & Key Data

ACS Global, Inc. (AMCY) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Jan 8, 2021. As of the latest trading session, AMCY stock price is $3.00, with a market capitalization of $171.3M. The stock has returned -40.00% over the past 12 months and +0.00% year-to-date.

Frequently Asked Questions

As of the latest trading session, ACS Global, Inc. (AMCY) stock price is $3.00. The stock is traded on OTC under the ticker symbol AMCY. The 52-week range is $3.00 – $3.00.

AMCY stock priceAMCY quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice